Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 4 versions: 3 with changes below, 1 re-verified with no change.
MinorChangedRegistry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Not Yet Recruiting
NotableStart date: Sep 15, 2024 to Dec 15, 2024v4
MinorStart date: Sep 1, 2024 to Sep 15, 2024v3
Study First Submitted
Notable: the plan changed
Minor: routine updates
Endpoints
Primary
Remifentanil consumption
Timeframe: Intraoperative
NRS Scores
Timeframe: Postoperative 1st, 6th, 12th and 24th hours
Morphine consumption
Timeframe: Postoperative 1st, 6th, 12th and 24th hours
Secondary (2)
Rescue analgesic
Nausea and vomiting
Arms and interventions
Analgesic use according to hemodynamics patients to be treatedActive comparator
Procedure/Surgery: Pericapsular nerve group block(PENG) Before the general anesthesia induction, Peng block will be performed between the psoas tendon and the ilium with 0.25% bupivacaine (20 mL) using ultrasound and will be adjusting opioid infusion rate according to hemodinamic parameters
Patients who will use analgesics according to NOL monitoringActive comparator
Procedure/Surgery: Pericapsular nerve group block(PENG) Before the general anesthesia induction, Peng block will be performed between the psoas tendon and the ilium with 0.25% bupivacaine (20 mL) using ultrasound and will be adjusting opioid infusion rate according to NOL monitoring.
Procedures: Those whose opioids were adjusted according to hemodynamic parameters, Those whose opioids were adjusted according to NOL monitoring